PN2034
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PN2034, covering 2007-08-23 to 2007-08-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) [Phase 2]